PIPMG - Key Persons
Corky has worked in the biopharmaceutical project management industry since 1998, where he started as the PM for the Viagra program at Pfizer. Corky joined Genentech in March 2006 as the Director of Development Project Management, tasked with creating from scratch a project management capability focused on supporting drug development teams.
He has since held PM leadership positions at companies such as Onyx, Theravance and BeiGene, and is currently a Global Program Director at EQRx. He was an instructor for DIA for ten years, teaching the New Drug Development and Lifecycle Management public course. Corky has spoken at many conferences and is the author of a chapter on project risk management in the book "Pharmaceutical and Biomedical Project Management in a Changing Global Environment" published by Wiley. His chapter is only slightly longer than the title of the book…
Job Titles:
- Member of the PIPMG Executive Committee
Jacqueline holds a PhD in Molecular Virology and brings with her experience gained from over 25 years in the biopharma industry from a variety of roles including clinical development, strategic planning and operations and programme leadership. Jacqueline has a broad portfolio of experience, having worked in orphan and rare disease, NCEs/ biologics, gene therapy, device, phases I-IV, companion diagnostics and is currently Program Head at Alvotech, leading the development and commercialization of biosimilar medicines.
PIPMG Role: Jacqueline has been a member of the PIPMG Executive committee since 2016 and is involved in all areas of PIPMG activity.
Job Titles:
- Founder and Director of Pellis Care Ltd
Janette Thomas (BSc, DiploD, PhD) is a director of PIPMG. Janette is Founder and Director of Pellis Care Ltd. She is an experienced senior executive with 22 years in the pharmaceutical and biotechnology industry. She has led R&D and international pharmaceutical drug development projects including for GlaxoSmithKline plc (LSE:GSK), CELS Ltd, Gardant, Jomaa Pharma GmbH, Immodulon Therapeutics Ltd, Horizon Discovery Group plc (LSE:HZD) and Atlnatic Healthcare Ltd. Her experience includes leading research projects, manufacturing outsourcing, large multinational consortia, and multinational pharmaceutical projects. Janette has a Diploma in Company Direction from the Institute of Directors, a PhD from University of Leicester, UK, and post doctoral research at Cambridge University, UK.
Karen is Chief Project and Portfolio Officer at the self-funding medical research charity LifeArc. Here she is accountable for shaping and leading their portfolio of Translational Challenges, which are ambitious research programmes focused on solving complex healthcare problems.
Karen has more than 25 years' experience within life sciences, from early exploratory to launch in a variety of therapeutic areas, having held numerous global leadership roles in portfolio management, pre-clinical and clinical development, R&D operations, product development and alliance management.
Prior to LifeArc, Karen held the role of VP Immuno-Oncology at the high-growth biotech BTG, where she was accountable for building their immunotherapy research portfolio through in-house research and collaborative partnerships. She began her R&D career within the pharmaceutical industry at Merck where she gained a strong grounding in drug discovery and has a DPhil in Pharmacology from the University of Oxford.
Pauline Stewart-Long (BSc, PhD) has worked in the pharmacuetical industry for over 30 years with roles of increasing seniority in both project and portfolio management. She has led R&D drug development projects as well as major organisational change projects. She left GlaxoSmithKline in 2012 to set up her own consultancy and has since worked with a variety of large, medium, small and start up companies developing organisation-specific solutions to meet client needs and ensuring the Project Management organisation acts as a catalyst for R&D strategy by providing staff with the skills to deliver projects. Pauline was the Chairperson of PIPMG from Dec 2014 until January 2021.
PIPMG Role: Pauline has been part of the PIPMG executive Committee for 10 years and was Chairperson for 6 years. She is involved in all areas of PIPMG activity but particularly focused on the future of the organisation and driving the strategy to meet the changing needs of the members.
Raffaella leads a team of Project Leaders, Clinical Study Managers and Portfolio Managers, at the Cancer Research UK Centre for Drug Development (CRUK CDD). CDD's clinical trial portfolio spans different therapeutic modalities through preclinical and early clinical phases. She started her career with a PhD and post-doc in cell biology at the Imperial Cancer Research Fund and EMBL (European Molecular Biology Laboratory) and has 20 years' experience in drug discovery and drug development project and portfolio management in the charity, academia and in the biotechnology sector, working at CRUK CDD and previously at Cellzome (a biotechnology company now part of GSK).
PIPMG Role: PIPMG Role: Raffaella is on the PIPMG Executive committee since 2018, working with the rest of the committee to deliver the agreed objectives of PIPMG.
Job Titles:
- Member of the PIPMG Executive Committee
Sandra started her career as an immunologist, and during the past 20 years has had various roles in program management and leadership within big pharma, CRO and biotech companies. During the past 9 years Sandra has focussed on oncology and is currently a Program Leader at Bicycle Therapeutics.
PIPMG Role: Sandra has been a member of the PIPMG Executive committee since 2017 and is involved in all areas of PIPMG activity.
Ilaria originally trained as molecular/cell biologist and has worked in the bio-pharmaceutical sector for over 20 years. She started her career in drug discovery across several therapeutic areas within big pharma (GSK and Novartis) before moving to the charity sector focusing on oncology. Ilaria has had various roles in program management, leadership and team management at the Cancer Research UK Centre for Drug Development and has let multi-disciplinary projects, developing small molecules, complex biologics, and cell therapies through preclinical and early clinical phases. Ilaria works at F-star Therapeutics as Director, Project Management.
Joe Stalder, PharmD, PMP, is the founder of Groundswell Pharma Consulting, based in San Diego, USA. Joe has more…
John began his career as a scientist in Immunology Diagnostics within the Wellcome Foundation (now GSK). He moved after some years to a new career in human resources as a trainer, team coach and eventually a learning and development Business Partner. He became a consultant in the 1990's, offering organization development, team building, skills training / coaching, instructional design and coordination. In 2001, he co-founded PPMLD Ltd with Ralph White, which specialises in enhancing collaborative working in life sciences - in particular, cross-functional project management and alliance / CRO outsourcing partnerships. John is also highly experienced in developing online, interactive support for learning and continues to innovate as this technology evolves.
Keith is an executive director, entrepreneur, senior consultant, strategic adviser, executive business coach, interim manager and project management professional. Working with many organisations large blue chip (GlaxoWellcome, Astra Zeneca), medium (Cambridge Antibody Technology, Emergent Biosolutions, Xenova), small (Fulcrum Pharma, Apitope, Intensichem), early stage, spin outs, academic/Universities (City- University of London) & not for profit organisations (eg PIPMG) for over 15 years. He provides Vision, Leadership, Strategy, Change & Executive Coaching - Inspiring & Transforming Organisations. In addition Keith is a Monitoring Officer for Innovate UK www.innovateuk.com, former Chair of Pharmaceutical Industry Project Management Group (PIPMG) www.pipmg.org and former Business Coach with Growth Accelerator www.growthaccelerator.com.
PIPMG Role: PIPMG Role: Keith has been part of the PIPMG executive committee for several years and has been involved in all areas of PIPMG activity including a term as Chairman.
Originally trained as a microbiologist, Steven has worked in the bio-pharmaceutical industry, for over 20 years. He has managed multi-disciplinary projects, developing both small molecules and complex biologics, across several therapeutic areas, including cancer, allergic disorders and pain.Working with some of the UK's foremost biotech companies, including Immodulon Therapeutics, Glide Technologies, Sosei R & D Ltd., and SR Pharma, he also spent some time at the Centre of Molecular Immunology (CIM) in Cuba, for the Canadian company YM Biosciences Inc. Previously, seven years at the Health Protection Agency (Public Health England), presented the first opportunity to develop programme and line management skills, coordinating high performing teams across a diverse range of National health, and defence programmes.
Denise started her career as a clinical biochemist who found that she was a natural project manager and loves project management with a passion. Denise has worked in the healthcare industry for over 25 years in a variety of companies e.g. Chiron, Bayer, Hexal, and PPD in project management roles encompassing R&D through to commercial and lifecycle management. She is currently COO, Kuano Ltd, UK.
PIPMG Role: Denise was elected Chairperson and Director for PIPMG since January 2021.
PIPMG Role: Mandy is on the PIPMG Executive committee, working with the rest of the committee to deliver the agreed objectives of PIPMG.
A Senior Director of Project Management within IMED Operations at AstraZeneca. Trained originally as chemist, I joined the…
Margaret has worked in the pharmaceutical industry for over 20 years. She is an accomplished Project and Programme Director,…
Job Titles:
- Tom Is Director, Global Program Leader Oncology at Ipsen and Has over 30 Years' Experience in the Pharmaceutical and
Tom is Director, Global Program Leader Oncology at Ipsen and has over 30 years' experience in the Pharmaceutical and…